Merck & Co., Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Merck & Co., Inc. (MRK) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $127.00 million for the 12-month period ending 2011-12-31, per its 10-K filed 2014-02-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2014-02-27
- Merck & Co., Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2011-12-31 was $0.00.
- Merck & Co., Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2011-09-30 was $0.00.
- Merck & Co., Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2011-06-30 was -$7.00M.
- Merck & Co., Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2011-03-31 was $134.00M.
- Merck & Co., Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2011 was $127.00M.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $0.00 derived: sum of 2 quarters · filed 2014-02-27 | -$7.00M derived: sum of 3 quarters · filed 2014-02-27 | $127.00M 10-K · filed 2014-02-27 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$7.00M derived: sum of 2 quarters · filed 2012-11-09 | $127.00M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $127.00M 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $134.00M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |